Work

A phase I/IIA safety study of NPC-1C: A novel, therapeutic antibody to treat pancreas and colorectal cancers.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.4_suppl.233

Authors: Michael Morse, Luis A. Diaz, Nilofer Saba Azad, Dan Laheru, Sherri Haley, Leanne Sophia Sleer, Philip M. Arlen

Institutions: Johns Hopkins University, Duke Medical Center, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4256507697

Cites:

Cited by: 2

Related to: 10